Buprenorphine-Naloxone vs Extended-Release Naltrexone Following Opioid Withdrawal Treatment.  Hsu HE, Lodi S, Yan S, et al.  JAMA Netw Open. 2026;9(7):e2623280. doi:10.1001/jamanetworkopen.2026.23280 https://jamanetwork.c…

Can Buprenorphine Be Overdosed? The Ceiling Effect and Its Clinical Implications.  Kozińska RB, Ślęzak J, Ilski I, Podsiadła M, Biedka K, Królewicz E.  Pharmaceuticals (Basel). 2026 Jun 6;19(6):903. doi: 10.3390/ph19060903. PMID: 4235652…

Buprenorphine long acting injectables: clinical needs, pharmacodynamic and pharmacokinetic basis, and design challenges for solid preformed implants.  Wang T, Biswas AA, Zhang F, Sun R, Hu M.  Eur J Pharm Biopharm. 2026 Jun 27:115170. do…

Enhancing Compliance Through Local Anesthesia in Extended-Release Buprenorphine Therapy: A Report of Two Cases.  Radparvar S.  Cureus. 2026 May 30;18(5):e109947. doi: 10.7759/cureus.109947. PMID: 42382868; PMCID: PMC13315220. https://pm…

Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial Tucciarone JM, Bandeira ID, Blasey C, Kratter IH, Ehrie J, Keller J, Pankow H, Chang M…

Relationship between extended-release buprenorphine adherence and reduced risk of return to use in patients with opioid use disorder: A retrospective claims data analysis. Jerry M, Venkat D, Flynn C, Tran AT, Abdel-Sattar M, Mullen W, Lane C. …